Sign In
Buy VERO
$0.268
+0 (+0%)
At Close: Jul 02, 2026
Venus Concept (NASDAQ:VERO) Price Target Lowered to $2.00 at Stifel Nicolaus
09:44am, Sunday, 14'th Nov 2021 Transcript Daily
Venus Concept (NASDAQ:VERO) had its price target reduced by analysts at Stifel Nicolaus from $2.50 to $2.00 in a report issued on Friday, The Fly reports. The firm currently has a hold rating on the stock. Stifel Nicolaus price objective would suggest a potential upside of 14.94% from the companys previous close. Separately, Zacks Investment []
Venus Concept Inc. (VERO) CEO Dom Serafino on Q3 2021 Results - Earnings Call Transcript
02:39pm, Friday, 12'th Nov 2021
Venus Concept Inc. (VERO) CEO Dom Serafino on Q3 2021 Results - Earnings Call Transcript
Venus Concept Stock Down As Q3 Earnings Trail Street Expectations
01:34pm, Friday, 12'th Nov 2021
Venus Concept Inc's (NASDAQ: VERO) Q3 sales increased 19% Y/Y to $24.6 million, missing the consensus of $26.43 million. On a sequential basis, the sales declined around 5%.
Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:48pm, Friday, 05'th Nov 2021
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept's Pain Management Device Scores FDA Nod
03:39pm, Tuesday, 19'th Oct 2021
The FDA has given 510(k) clearance to Venus Concept Inc's (NASDAQ: VERO) Venus Freedom device for pain management. Venus Freedom is a noninvasive, non-ablative device with three applicators to del
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
07:30am, Tuesday, 19'th Oct 2021
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has recei
Venus Concept Appoints Ross J. Portaro as President of Global Sales
07:30am, Tuesday, 12'th Oct 2021
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the appointment o
Venus Concept to Release Third Quarter of Fiscal Year 2021 Financial Results on November 12, 2021
04:05pm, Monday, 04'th Oct 2021
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of f
Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
04:05pm, Tuesday, 07'th Sep 2021
TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that managemen
Forget Bargains, Play 5 Stocks with Rising P/E Instead
05:30pm, Thursday, 02'nd Sep 2021
Forget undervalued stocks, there is room for upside even in stocks with rising P/E.
Venus Concept Inc. (VERO) CEO Dom Serafino on Q2 2021 Results - Earnings Call Transcript
02:32pm, Friday, 13'th Aug 2021
Venus Concept Inc. (VERO) CEO Dom Serafino on Q2 2021 Results - Earnings Call Transcript
Venus Concept Stock Trades Higher After Lifting FY21 Sales Outlook
11:19am, Friday, 13'th Aug 2021
Venus Concept Inc's (NASDAQ: VERO) Q2 sales increased 52% Y/Y to $25.8 million, beating the consensus of $24.26 million. The increase by product category was driven by a 71% increase in lease revenu
Venus Concept (VERO) Reports Q2 Loss, Tops Revenue Estimates
10:06am, Friday, 13'th Aug 2021
Venus Concept (VERO) delivered earnings and revenue surprises of 71.43% and 6.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept Shares Increase Over 15% Pre-Market: Why It Happened
07:54am, Friday, 13'th Aug 2021
The shares of Venus Concept Inc. (NASDAQ: VERO) increased by over 15% pre-market. This is why it happened.
Recap: Venus Concept Q2 Earnings
07:37am, Friday, 13'th Aug 2021
Shares of Venus Concept (NASDAQ:VERO) rose 15.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 102.56% year over year to $0.01, which beat t
